24/7 Market News (NASDAQ: AVRO) AVROBIO INC. has received news this morning that has shares up more than 10% on 1100 plus trades and light volume.

The company is trading at $1.08 and looks to improve on FDA granting orphan drug designation.

[mstock id=”73007″ asset=”avro”]

AVROBIO Receives Orphan Drug Designation from the U.S. Food and Drug Administration for AVR-RD-05, a Gene Therapy for Mucopolysaccharidosis Type II (MPSII) or Hunter Syndrome


NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.